Abstract

Briefly described, embodiments of this disclosure include compositions, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of treating HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.


Claims
CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jun 23, 2015
  • Application: Sep 18, 2008
    US US 67798908 A
  • Priority: Sep 18, 2008
    US US 67798908 A
  • Priority: Sep 18, 2008
    US US 2008/0076806 W
  • Priority: Aug 28, 2008
    US US 9253708 P
  • Priority: Aug 14, 2008
    US US 8875908 P
  • Priority: Sep 18, 2007
    US US 97330907 P

Download Citation


Sign in to the Lens

Feedback